A Study for the Collection of Clinical Data for Stroke Patients and Healthy Subjects
Launched by BUNDANG CHA HOSPITAL · Jun 8, 2023
Trial Information
Current as of June 06, 2025
Unknown status
Keywords
ClinConnect Summary
This clinical trial is looking to gather and compare medical information from stroke patients and healthy individuals. The goal is to understand the differences in health and physical abilities between those who have had a stroke and those who have not. By collecting data over time, researchers hope to learn more about how strokes affect people and what factors might influence recovery.
To participate in this study, stroke patients need to be at least 20 years old and must be more than a month post-stroke. They should be able to understand the study details and agree to join. Healthy volunteers are also welcome if they are over 20, live independently, and agree to participate after understanding the study. Participants will be asked to provide information about their health and may undergo various assessments. It's important to note that certain health conditions may prevent individuals from joining the study, but those currently involved in other studies may still participate.
Gender
ALL
Eligibility criteria
- 1. For stroke patients 1) Inclusion Criteria:
- • Adults over 20 years of age
- • More than 1 month after onset of stroke
- * After hearing a detailed explanation of this study and fully understanding it, the subject or legal representative voluntarily decides to participate and agrees in writing to observe the precautions 2) Exclusion criteria:
- • Patients who correspond to one or more of the following cannot participate in the study.
- • Patients with systemic infectious symptoms at the time of participation in the study
- • In the case of a person with impaired ability to consent (less than 10 points on the MMSE), a person who is not accompanied by a guardian
- • Those with severe medical conditions such as unstable conditions in the cardiovascular system, digestive system, respiratory system, endocrine system, etc., and those with poor general health
- • Other cases where the researcher judges that participation in this study is not suitable(Patients who are participating in other clinical trials or studies, or who have participated in other clinical trials or studies within the past 30 days can also participate in this study.)
- 2. For healthy voluteers 1) Inclusion Criteria:
- • Over 20 years of age
- • A person who is performing an independent daily life
- • A person who voluntarily decides to participate and agrees in writing to abide by the precautions after hearing a detailed explanation of this study and fully understanding it
- 2) Exclusion criteria:
- • Patients who correspond to one or more of the following cannot participate in the study.
- • MMSE score less than 20 points (from 19 points onwards excluded from study)
- • Those who remain disabled due to brain disease (stroke, brain tumor, cerebral palsy, dementia, Parkinson's disease, etc.)
- • Those with severe medical conditions such as unstable conditions in the cardiovascular system, digestive system, respiratory system, endocrine system, etc., and those with poor general health
- • Other cases where the researcher judges that participation in this study is not suitable (Patients who are participating in other clinical trials or studies, or who have participated in other clinical trials or studies within the past 30 days can also participate in this study.)
About Bundang Cha Hospital
Bundang CHA Hospital is a leading healthcare institution located in South Korea, renowned for its commitment to innovative medical research and patient-centered care. As a prominent clinical trial sponsor, the hospital leverages its advanced facilities and multidisciplinary expertise to conduct rigorous clinical studies across various therapeutic areas. With a focus on advancing medical knowledge and improving treatment outcomes, Bundang CHA Hospital collaborates with a network of esteemed researchers and healthcare professionals to ensure the highest standards of clinical excellence and ethical practices in all its trials.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Seongnam, , Korea, Republic Of
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported